A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies
Clinical trial NCT07368478 · RECRUITING
Trial details
- NCT number
- NCT07368478
- Sponsor
- Biocity Biopharmaceutics Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-24
- Primary completion
- 2027-12-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.